Literature DB >> 5533681

Solid-phase synthesis of (4-threonine)-oxytocin. A more potent and specific oxytocic agent than oxytocin.

M Manning, E Coy, W H Sawyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5533681     DOI： 10.1021/bi00822a010

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  7 in total

1.  Cyclic and linear vasopressin V1 and V1/V2 antagonists containing arginine in the 4-position.

Authors:  W H Sawyer; B Lammek; A Misicka; M Kruszynski; A Kolodzieczyk; M Manning
Journal:  Experientia       Date:  1991-01-15

2.  Biological properties of synthetic Ser 4 -Arg 8 -oxytocin (Ile 3 -Ser 4 -arginine vasopressin): role of the residue No. 4 in the hormone-pressor receptor interaction.

Authors:  J Chauvet; M T Chauvet; R Acher
Journal:  Experientia       Date:  1972-12-15

3.  Pharmacology of hydroxy-analogues of oxytocin.

Authors:  D B Hope
Journal:  Proc R Soc Med       Date:  1974-01

4.  The deamino derivatives of (4-threonine)-oxytocin and (4-threonine)-mesotocin; analogs possessing a surprising spectrum of diminished pharmacological activities.

Authors:  M Manning; E J Coy; W H Sawyer
Journal:  Experientia       Date:  1971

5.  Revisiting oxytocin through the medium of isonitriles.

Authors:  Ting Wang; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2012-08-02       Impact factor: 15.419

6.  Invertebrate neuropeptides resembling vasotocin and some analogues: synthesis and pharmacological properties.

Authors:  M Kruszyński; M Manning; N C Wo; W H Sawyer
Journal:  Experientia       Date:  1990-07-15

7.  Binding of [3H]oxytocin to cells isolated from the mammary gland of the lactating rat.

Authors:  B T Schroeder; J Chakraborty; M S Soloff
Journal:  J Cell Biol       Date:  1977-08       Impact factor: 10.539
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.